01Jan
01Jan
Congress Extends Student Loan Repayment Provision to 2025
Employers will be allowed to make tax-free contributions of up to $5,250 per employee annually toward eligible education expenses, including tuition or student loan assistance. The passage this week of the stimulus bill approved by Congress preserves the tax-free status of employer payments toward employee student loans through 2025, a marked difference from the year-end expiration date included in the Coronavirus Aid, Relief and Economic Security (CARES) Act... The CARES Act’s semi-permanent status meant fewer employers were willing to...
31Dec
Cognoptix Announces Formation of a New Board of Directors
Cognoptix is a breakthrough diagnostics company developing an innovative office-based device-drug system for the early detection of Alzheimer's disease (AD). As another milestone of the Series R restart, recapitalization, and revitalization, the company named a new Board of Directors (BOD) formed under the leadership of Dr. Susanne Wilke, Ph.D., Cognoptix' new President and CEO. Read more >>
31Dec
Here are the top angel groups between the coasts
The economic upheaval caused by the Covid-19 pandemic has created a once-in-a-generation surge of startups across the U.S. According to government data and a Goldman Sachs report, the share of Americans starting new businesses has risen sharply in 2020. Boston Harbor Angels on the list of top angel groups. Read more >>
30Dec
Groton Connecticut based Astrocyte Pharmaceuticals is raising $8,655,148.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Astrocyte Pharmaceuticals is raising $8,655,148.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, William Korinek played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development. Read more >>
30Dec
ZetrOZ Systems’ Wearable Ultrasound Device, SAM, Receives Expanded FDA Re-Approval, Positioning the Company for Market Growth in 2021
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, is the global leader in development of SAM technologies. With its reapproval for expanded use in 2020, the use of SAM ultrasound technology in both professional and at-home applications is expected to increase market growth significantly over the next several years. Read more >>
23Dec
Teenager Gets Gift of Sight
When Jimy Rubio came to tour the SEA LIFE and Legoland Discovery Center in Grapevine, he didn't know he would leave with a life-changing gift. Jimy Rubio toured the SEA LIFE and Legoland Discovery Center on Monday with the help of a device called eSight 4, allowing him to see things he's never been able to see on his own. Read more >>
23Dec
Happy Holidays!
We wish all our friends a safe and healthy Holiday Season!
22Dec
Endocannabinoid Pathway Targeted Drug Demonstrates Proof-of-Concept Efficacy in a Cutaneous Lupus Erythematosus Mouse Model
Hoth has a partnership agreement with Zylö Therapeutics Inc., to co-develop a new topical treatment for patients with Cutaneous Lupus Erythematosus (CLE), a chronic autoimmune disease that affects the skin and is associated with a significant burden on patient quality of life. Read more >>
22Dec